![Agenus Inc Publishes Promising Results of Phase 1b Study on Combination Therapy for Ovarian Cancer - Best Stocks Agenus Inc Publishes Promising Results of Phase 1b Study on Combination Therapy for Ovarian Cancer - Best Stocks](https://beststocks.com/wp-content/uploads/2023/03/Pharmaceuticals-3.jpg)
Agenus Inc Publishes Promising Results of Phase 1b Study on Combination Therapy for Ovarian Cancer - Best Stocks
Earnings Flash (AGEN) AGENUS Reports Q2 Revenue $25.3M, vs. Street Est of $24.1M -August 08, 2023 at 07:37 am EDT | MarketScreener
![Agenus Stock Forecast: down to 0.641 USD? - AGEN Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Agenus Stock Forecast: down to 0.641 USD? - AGEN Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/7c/stock-agen-stock-forecast-short.png?v=1698432054)
Agenus Stock Forecast: down to 0.641 USD? - AGEN Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Transcript : Agenus Inc. Presents at 5th Annual Guggenheim Oncology Days, Feb-09-2023 09 -February 09, 2023 at 09:35 am EST | MarketScreener
![Agenus Stock Forecast: down to 0.641 USD? - AGEN Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Agenus Stock Forecast: down to 0.641 USD? - AGEN Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/7c/stock-agen-stock-forecast.png?v=1698067328)